IP Library Granted Patent US 8,080,392
Granted Patent B2
US 8,080,392 · App. 13/025,002 · Granted Dec 20, 2011

IL-D80 polynucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,080,392
App. No.
13/025,002
Granted
Dec 20, 2011
Kind
B2
Abstract

Purified genes encoding a cytokine or composite cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding these molecules are provided. Methods of using said reagents and diagnostic kits are also provided.

Claims (11)

1. An isolated polynucleotide encoding an IL-D80 polypeptide comprising an amino acid sequence having at least 95% sequence identity with the mature amino acid sequence of SEQ ID NO: 6, wherein the polypeptide can form a composite cytokine with human EBI3 that binds to a receptor comprising WSX-1/TCCR.

2. The isolated polynucleotide of claim 1 , wherein the polypeptide comprises an amino acid sequence differing from the mature amino acid sequence of SEQ ID NO: 6 by five or fewer amino acid changes.

3. The isolated polynucleotide of claim 2 , wherein the polypeptide comprises an amino acid sequence differing from the mature amino acid sequence of SEQ ID NO: 6 by one or fewer amino acid changes.

4. The isolated polynucleotide of claim 3 , wherein the polypeptide comprises the mature amino acid sequence of SEQ ID NO: 6.

5. An isolated polynucleotide of claim 1 comprising at least 35 contiguous nucleotides of the coding portion of SEQ ID NO: 5.

6. An expression vector comprising the polynucleotide of claim 1 .

7. An isolated host cell containing the expression vector of claim 6 .

8. The host cell of claim 7 wherein the cell is a eukaryotic cell.

9. A method of producing an IL-D80polypeptide encoded by the polynucleotide of claim 1 comprising:

a) culturing a host cell containing an expression vector comprising said polynucleotide under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →